Skip to content

Contact +44 (0) 20 7060 7474 email us

Pipeline

Research & Development (R&D) Company Pipeline

In this section you can find business information covering life science companies' R&D pipelines. Reports can including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail, product revenue, trademarks, corporate partners and management profiles.

Stay up-to-date with new products added to this category »
Title Publication Date Price
Attention Deficit Hyperactivity Disorder (ADHD)
Drug Pipeline Analysis and Market Forecasts to 2015
 December 2009 £1305
Major Depressive Disorder (MDD)
Drug Pipeline Analysis and Market Forecasts to 2015
 December 2009 £1305
Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012
 December 2008 £2285
Pipeline Insight: Orphan Diseases in Neurology Part III: Myasthenia Gravis
 November 2008 £3915
Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value
 October 2008 £5225
Intelligent Medical Devices, Inc. Product Pipeline Analysis
 August 2008 £490
InterGenetics Incorporated Product Pipeline Analysis
 August 2008 £490
Interface Biologics, Inc. Product Pipeline Analysis
 August 2008 £490
Inolase Ltd. Product Pipeline Analysis
 August 2008 £490
Innovent Medical Solutions, Ltd. Product Pipeline Analysis
 August 2008 £490
IRIS International, Inc. Product Pipeline Analysis
 August 2008 £490
Implants International Limited Product Pipeline Analysis
 August 2008 £490
Innocoll Technologies Ltd Product Pipeline Analysis
 August 2008 £490
Interleukin Genetics Incorporated Product Pipeline Analysis
 August 2008 £490
Ivoclar Vivadent AG Product Pipeline Analysis
 August 2008 £490
Kiscomedica Product Pipeline Analysis
 August 2008 £490
Kuros Biosurgery AG Product Pipeline Analysis
 August 2008 £490
Kyphon Inc. Product Pipeline Analysis
 August 2008 £490
Kensey Nash Corporation Product Pipeline Analysis
 August 2008 £490
JenaValve Technology GmbH Product Pipeline Analysis
 August 2008 £490
Jarvik Heart, Inc. Product Pipeline Analysis
 August 2008 £490
Jemo Spine, LLC. Product Pipeline Analysis
 August 2008 £490
IMEXCO General Ltd. Product Pipeline Analysis
 August 2008 £490
Hologic, Inc. Product Pipeline Analysis
 August 2008 £490
FzioMed, Inc. Product Pipeline Analysis
 August 2008 £490
GRANT Life Sciences, Inc. Product Pipeline Analysis
 August 2008 £490
Gen-Probe Incorporated Product Pipeline Analysis
 August 2008 £490
Foster-Miller, Inc. Product Pipeline Analysis
 August 2008 £490
FUJIFILM Medical Systems USA, Inc. Product Pipeline Analysis
 August 2008 £490
Eurocor GmbH Product Pipeline Analysis
 August 2008 £490
ExonHit Therapeutics SA Product Pipeline Analysis
 August 2008 £490
Gene Express, Inc. Product Pipeline Analysis
 August 2008 £490
Genzyme Corporation Product Pipeline Analysis
 August 2008 £490
Endovasc, Inc. Product Pipeline Analysis
 August 2008 £490
LeMaitre Vascular, Inc. Product Pipeline Analysis
 August 2008 £490
HeartWare Limited Product Pipeline Analysis
 August 2008 £490
Epigenomics AG Product Pipeline Analysis
 August 2008 £490
Hai Kang Life Corporation Limited Product Pipeline Analysis
 August 2008 £490
Glycominds Ltd. Product Pipeline Analysis
 August 2008 £490
Greatbatch, Inc. Product Pipeline Analysis
 August 2008 £490
Epinex Diagnostics Incorporated Product Pipeline Analysis
 August 2008 £490
Lifecore Biomedical, Inc. Product Pipeline Analysis
 August 2008 £490
OccuLogix, Inc. Product Pipeline Analysis
 August 2008 £490
Omrix Biopharmaceuticals, Inc. Product Pipeline Analysis
 August 2008 £490
Onconome, Inc. Product Pipeline Analysis
 August 2008 £490
Novo Nordisk AS Product Pipeline Analysis
 August 2008 £490
Northstar Neuroscience, Inc. Product Pipeline Analysis
 August 2008 £490
Nexa Orthopedics, Inc. Product Pipeline Analysis
 August 2008 £490
Nicast LTD Product Pipeline Analysis
 August 2008 £490
Non-Invasive Monitoring Systems, Inc. Product Pipeline Analysis
 August 2008 £490
Optiscan Imaging Limited Product Pipeline Analysis
 August 2008 £490
OraSure Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
OxyBand Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
Paieon Inc. Product Pipeline Analysis
 August 2008 £490
Perceptronix Medical Inc. Product Pipeline Analysis
 August 2008 £490
Osmetech plc Product Pipeline Analysis
 August 2008 £490
Orthovita, Inc. Product Pipeline Analysis
 August 2008 £490
Orion Genomics Product Pipeline Analysis
 August 2008 £490
Ornim, Inc. Product Pipeline Analysis
 August 2008 £490
Ortec International, Inc. Product Pipeline Analysis
 August 2008 £490
Nerites Corporation Product Pipeline Analysis
 August 2008 £490
NMT Medical, Inc. Product Pipeline Analysis
 August 2008 £490
Malaysian Bio-Diagnostics Research Sdn Bhd Product Pipeline Analysis
 August 2008 £490
MedWaves Incorporated Product Pipeline Analysis
 August 2008 £490
Medlogics Device Corporation Product Pipeline Analysis
 August 2008 £490
MND DIAGNOSTIC LTD. Product Pipeline Analysis
 August 2008 £490
MC3, Inc. Product Pipeline Analysis
 August 2008 £490
Edwards Lifesciences Corporation Product Pipeline Analysis
 August 2008 £490
LightLab Imaging, Inc. Product Pipeline Analysis
 August 2008 £490
Lombard Medical Technologies PLC Product Pipeline Analysis
 August 2008 £490
Medtronic, Inc. Product Pipeline Analysis
 August 2008 £490
Merit Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £490
Minos Medical Inc. Product Pipeline Analysis
 August 2008 £490
Miraculins Inc. Product Pipeline Analysis
 August 2008 £490
NIDEK CO., LTD. Product Pipeline Analysis
 August 2008 £490
Mindray Medical International Limited Product Pipeline Analysis
 August 2008 £490
Milagen, Inc. Product Pipeline Analysis
 August 2008 £490
MicroMed Cardiovascular, Inc. Product Pipeline Analysis
 August 2008 £490
Micrus Endovascular Corporation Product Pipeline Analysis
 August 2008 £490
Levitronix LLC Product Pipeline Analysis
 August 2008 £490
ENTrigue Surgical, Inc. Product Pipeline Analysis
 August 2008 £490
Asclepion Laser Technologies GmbH Product Pipeline Analysis
 August 2008 £490
Ash Access Technology, Inc. Product Pipeline Analysis
 August 2008 £490
AtriCure, Inc. Product Pipeline Analysis
 August 2008 £490
Artimplant AB Product Pipeline Analysis
 August 2008 £490
Arthro Kinetics plc Product Pipeline Analysis
 August 2008 £490
Angiotech Pharmaceuticals, Inc. Product Pipeline Analysis
 August 2008 £490
Aptus Endosystems, Inc. Product Pipeline Analysis
 August 2008 £490
Arrow International, Inc. Product Pipeline Analysis
 August 2008 £490
AutoGenomics, Inc. Product Pipeline Analysis
 August 2008 £490
Ayanda Biosystems S.A. Product Pipeline Analysis
 August 2008 £490
Berlin Heart GmbH Product Pipeline Analysis
 August 2008 £490
Bio-Spine Corp. Product Pipeline Analysis
 August 2008 £490
BioCure, Inc. Product Pipeline Analysis
 August 2008 £490
Beckman Coulter, Inc. Product Pipeline Analysis
 August 2008 £490
Bayer HealthCare AG Product Pipeline Analysis
 August 2008 £490
BG Medicine, Inc. Product Pipeline Analysis
 August 2008 £490
BSD Medical Corporation Product Pipeline Analysis
 August 2008 £490
Bausch & Lomb Incorporated Product Pipeline Analysis
 August 2008 £490
Analogic Corporation Product Pipeline Analysis
 August 2008 £490
Amic AB Product Pipeline Analysis
 August 2008 £490
Abbott Diagnostics Product Pipeline Analysis
 August 2008 £490
Access Bio, Inc. Product Pipeline Analysis
 August 2008 £490
AccuTech, LLC Product Pipeline Analysis
 August 2008 £490
AOI Medical, Inc. Product Pipeline Analysis
 August 2008 £490
AI Medical Devices Inc. Product Pipeline Analysis
 August 2008 £490
8sens.biognostic GmbH Product Pipeline Analysis
 August 2008 £490
A&G Pharmaceutical, Inc. Product Pipeline Analysis
 August 2008 £490
A-Spine Holding Group Corp. Product Pipeline Analysis
 August 2008 £490
Active Implants Corporation Product Pipeline Analysis
 August 2008 £490
AdnaGen AG Product Pipeline Analysis
 August 2008 £490
Alfa Scientific Designs, Inc. Product Pipeline Analysis
 August 2008 £490
Align Technology, Inc. Product Pipeline Analysis
 August 2008 £490
Alphatec Holdings, Inc. Product Pipeline Analysis
 August 2008 £490
Alcon, Inc. Product Pipeline Analysis
 August 2008 £490
Advanced Surgical Design & Manufacture Limited Product Pipeline Analysis
 August 2008 £490
Advanced Medical Optics, Inc. Product Pipeline Analysis
 August 2008 £490
Advanced Refractive Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
BioTex, Inc. Product Pipeline Analysis
 August 2008 £490
Bioheart, Inc. Product Pipeline Analysis
 August 2008 £490
Corgenix, Inc. Product Pipeline Analysis
 August 2008 £490
Corin Group PLC Product Pipeline Analysis
 August 2008 £490
Correlogic Systems, Inc. Product Pipeline Analysis
 August 2008 £490
Cordis Corporation Product Pipeline Analysis
 August 2008 £490
CorNova, Inc. Product Pipeline Analysis
 August 2008 £490
Confluent Surgical Inc. Product Pipeline Analysis
 August 2008 £490
Cook Medical Product Pipeline Analysis
 August 2008 £490
CorAssist Cardiovascular Ltd. Product Pipeline Analysis
 August 2008 £490
CryoLife, Inc. Product Pipeline Analysis
 August 2008 £490
Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis
 August 2008 £490
Disc Motion Technologies Product Pipeline Analysis
 August 2008 £490
Doxa AB Product Pipeline Analysis
 August 2008 £490
Philips Medical Systems Product Pipeline Analysis
 August 2008 £490
DiaGenic ASA Product Pipeline Analysis
 August 2008 £490
Debiotech S.A. Product Pipeline Analysis
 August 2008 £490
CytoCore, Inc. Product Pipeline Analysis
 August 2008 £490
DNAPrint Genomics, Inc. Product Pipeline Analysis
 August 2008 £490
DePuy, Inc. Product Pipeline Analysis
 August 2008 £490
CompuMed, Inc. Product Pipeline Analysis
 August 2008 £490
Collagen Matrix, Inc. Product Pipeline Analysis
 August 2008 £490
Boston Scientific Corporation Product Pipeline Analysis
 August 2008 £490
C.R. Bard, Inc. Product Pipeline Analysis
 August 2008 £490
Cardima, Inc. Product Pipeline Analysis
 August 2008 £490
Biotest Diagnostics Corporation Product Pipeline Analysis
 August 2008 £490
Biosite Incorporated Product Pipeline Analysis
 August 2008 £490
Biomet, Inc. Product Pipeline Analysis
 August 2008 £490
Bioring SA Product Pipeline Analysis
 August 2008 £490
Bioscan Technologies Inc. Product Pipeline Analysis
 August 2008 £490
Cardiogenesis Corporation Product Pipeline Analysis
 August 2008 £490
Carestream Health, Inc. Kodak Health Group Product Pipeline Analysis
 August 2008 £490
China Medical Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
China Sky One Medical, Inc. Product Pipeline Analysis
 August 2008 £490
Clinical Cell Culture Limited Product Pipeline Analysis
 August 2008 £490
Chembio Diagnostic Systems, Inc. Product Pipeline Analysis
 August 2008 £490
CellTran Limited Product Pipeline Analysis
 August 2008 £490
Carl Zeiss Meditec AG Product Pipeline Analysis
 August 2008 £490
CathRx Ltd Product Pipeline Analysis
 August 2008 £490
Eden Spine, LLC Product Pipeline Analysis
 August 2008 £490
Hansen Medical, Inc. Product Pipeline Analysis
 August 2008 £490
Translumina GmbH Product Pipeline Analysis
 August 2008 £490
pSivida Limited Product Pipeline Analysis
 August 2008 £490
ev3 Inc. Product Pipeline Analysis
 August 2008 £490
diaDexus, Inc. Product Pipeline Analysis
 August 2008 £490
AGA Medical Corporation Product Pipeline Analysis
 August 2008 £490
BIOTRONIK GmbH & Co. KG Product Pipeline Analysis
 August 2008 £490
BodyTel Scientific Inc. Product Pipeline Analysis
 August 2008 £490
Biocompatibles International plc Product Pipeline Analysis
 August 2008 £490
BioTech One Inc Product Pipeline Analysis
 August 2008 £490
aap Implantate AG Product Pipeline Analysis
 August 2008 £490
Zimmer Holdings, Inc. Product Pipeline Analysis
 August 2008 £490
VentriPoint, Inc. Product Pipeline Analysis
 August 2008 £490
Ventana Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £490
VERTEBRON Inc. Product Pipeline Analysis
 August 2008 £490
U.S. Spinal Technologies, LLC Product Pipeline Analysis
 August 2008 £490
Veryan Medical Product Pipeline Analysis
 August 2008 £490
Visual Pathways, Inc. Product Pipeline Analysis
 August 2008 £490
ZONARE Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £490
Xhale Diagnostics, Inc. Product Pipeline Analysis
 August 2008 £490
XTENT, Inc. Product Pipeline Analysis
 August 2008 £490
CSMG Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
Cepheid Product Pipeline Analysis
 August 2008 £490
KYOCERA Corporation Product Pipeline Analysis
 August 2008 £490
LDR Holding Corporation Product Pipeline Analysis
 August 2008 £490
LifeAssays AB Product Pipeline Analysis
 August 2008 £490
MAKO Surgical Corp. Product Pipeline Analysis
 August 2008 £490
Insight MRI Product Pipeline Analysis
 August 2008 £490
Innova Biotechnology Co., Ltd. Product Pipeline Analysis
 August 2008 £490
Protein Polymer Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
Globus Medical, Inc. Product Pipeline Analysis
 August 2008 £490
Inion Oy Product Pipeline Analysis
 August 2008 £490
Pioneer Surgical Technology, Inc. Product Pipeline Analysis
 August 2008 £490
Reliant Technologies Inc. Product Pipeline Analysis
 August 2008 £490
ECI Biotech Inc. Product Pipeline Analysis
 August 2008 £490
Diazyme Laboratories Product Pipeline Analysis
 August 2008 £490
CooperVision, Inc. Product Pipeline Analysis
 August 2008 £490
GUIDED THERAPEUTICS, INC. Product Pipeline Analysis
 August 2008 £490
Gambro AB Product Pipeline Analysis
 August 2008 £490
Scient'x USA Product Pipeline Analysis
 August 2008 £260
Siemens AG Product Pipeline Analysis
 August 2008 £490
Sorin S.p.A. Product Pipeline Analysis
 August 2008 £490
Toshiba America Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £490
eXagen DIAGNOSTICS, Inc. Product Pipeline Analysis
 August 2008 £490
Shina Systems Ltd. Product Pipeline Analysis
 August 2008 £490
Serica Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
Sequella, Inc. Product Pipeline Analysis
 August 2008 £490
SensiGen, LLC. Product Pipeline Analysis
 August 2008 £490
Siemens Medical Solutions Product Pipeline Analysis
 August 2008 £490
Sientra, Inc. Product Pipeline Analysis
 August 2008 £490
Spine Smith, LP Product Pipeline Analysis
 August 2008 £490
Smith & Nephew Plc Product Pipeline Analysis
 August 2008 £490
Small Bone Innovations, Inc. Product Pipeline Analysis
 August 2008 £490
Sahajanand Medical technologies Pvt. Ltd. Product Pipeline Analysis
 August 2008 £490
Tissue Repair Company Product Pipeline Analysis
 August 2008 £490
Ranier Technology Limited Product Pipeline Analysis
 August 2008 £490
Rafael Medical Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
Qiagen N.V. Product Pipeline Analysis
 August 2008 £490
QUASAR, Inc. Product Pipeline Analysis
 August 2008 £490
Raymedica, LLC Product Pipeline Analysis
 August 2008 £490
Regentis Biomaterials Ltd. Product Pipeline Analysis
 August 2008 £490
SQI Diagnostics Inc. Product Pipeline Analysis
 August 2008 £490
SEQUENOM, Inc. Product Pipeline Analysis
 August 2008 £490
Roche Diagnostics Limited Product Pipeline Analysis
 August 2008 £490
SpineCraft, Inc. Product Pipeline Analysis
 August 2008 £490
STAAR Surgical Company Product Pipeline Analysis
 August 2008 £490
The Magstim Company Limited Product Pipeline Analysis
 August 2008 £490
Terumo Corporation Product Pipeline Analysis
 August 2008 £490
Tepha, Inc. Product Pipeline Analysis
 August 2008 £490
Targeted Diagnostics & Therapeutics, Inc. Product Pipeline Analysis
 August 2008 £490
Theken Spine, LLC Product Pipeline Analysis
 August 2008 £490
ThermoGenesis Corp. Product Pipeline Analysis
 August 2008 £490
Spire Corporation Product Pipeline Analysis
 August 2008 £490
Thoratec Corporation Product Pipeline Analysis
 August 2008 £490
Third Wave Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
Target Discovery, Inc. Product Pipeline Analysis
 August 2008 £490
The Spectranetics Corporation Product Pipeline Analysis
 August 2008 £490
Stryker Corporation Product Pipeline Analysis
 August 2008 £490
Straumann Holding AG Product Pipeline Analysis
 August 2008 £490
TEKIA, INC. Product Pipeline Analysis
 August 2008 £490
St. Jude Medical Inc. Product Pipeline Analysis
 August 2008 £490
Symphony Medical, Inc. Product Pipeline Analysis
 August 2008 £490
SutureAid Product Pipeline Analysis
 August 2008 £490
Synovis Life Technologies, Inc. Product Pipeline Analysis
 August 2008 £490
SyntheMed, Inc. Product Pipeline Analysis
 August 2008 £490
Pipeline Insight: Non-insulin antidiabetics Incretin mimetics leaders in a diverse pipeline
 May 2008 £3915
Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report
 February 2008 £650
Kidneys and Genito-Urinary System - Diabetic Nephropathy Drug Pipeline Report
 February 2008 £650
Kidney Cancer Drug Pipeline Report
 February 2008 £975
Infections - Urinary Tract Infections Drug Pipeline Report
 February 2008 £650
Kidneys and Genito-Urinary System - Erectile Dysfunction Drug Pipeline Report
 February 2008 £650
Infections - Viral Infections Drug Pipeline Report
 February 2008 £650
Liver Cancer Drug Pipeline Report
 February 2008 £650
Infections - Tuberculosis Drug Pipeline Report
 February 2008 £650
Melanoma or Skin Cancer Drug Pipeline Report
 February 2008 £975
Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline Report
 February 2008 £650
Kidneys and Genito-Urinary System - Overactive Bladder Drug Pipeline Report
 February 2008 £650
Kidneys and Genito-Urinary System - Kidney Stones Drug Pipeline Report
 February 2008 £650
Kidneys and Genito-Urinary System - Hyperphosphatemia Drug Pipeline Report
 February 2008 £650
Infections - Ear Infections Drug Pipeline Report
 February 2008 £650
Infections - Fungal Infections or Candidiasis Drug Pipeline Report
 February 2008 £975
Infections - Helminthic Infestations Drug Pipeline Report
 February 2008 £650
Infections - Fever Drug Pipeline Report
 February 2008 £650
Infections - Bacterial Infections Drug Pipeline Report
 February 2008 £975
Metabolic Endocrinology - Cachexia Drug Pipeline Report
 February 2008 £650
Infections - Hepatitis B Drug Pipeline Report
 February 2008 £975
Infections - Hepatitis C Drug Pipeline Report
 February 2008 £975
Infections - Pneumonia Drug Pipeline Report
 February 2008 £975
Infections - Malaria Drug Pipeline Report
 February 2008 £650
Infections - Influenza Drug Pipeline Report
 February 2008 £975
Infections - Herpes Simplex Virus Infection Drug Pipeline Report
 February 2008 £650
Infections - Staphylococcal Infections Drug Pipeline Report
 February 2008 £975
Infections - AIDS HIV Drug Pipeline Report
 February 2008 £975
Respiratory and Pulmonary System - Chronic Obstructive Pulmonary Disease Drug Pipeline Report
 February 2008 £975
Respiratory and Pulmonary System - Cough Drug Pipeline Report
 February 2008 £650
Respiratory and Pulmonary System - Cystic Fibrosis Drug Pipeline Report
 February 2008 £650
Respiratory and Pulmonary System - Nasal congestion Drug Pipeline Report
 February 2008 £650
Respiratory and Pulmonary System - Bronchospasm Drug Pipeline Report
 February 2008 £650
Respiratory and Pulmonary System - Bronchitis Drug Pipeline Report
 February 2008 £650
Pancreatic Cancer Drug Pipeline Report
 February 2008 £975
Prostate Cancer Drug Pipeline Report
 February 2008 £975
Respiratory and Pulmonary System - Asthma Drug Pipeline Report
 February 2008 £975
Substance Abuse - Alcoholism Drug Pipeline Report
 February 2008 £650
Substance Abuse - Antidote Drug Pipeline Report
 February 2008 £650
Women's Health - Menopausal Symptoms Drug Pipeline Report
 February 2008 £650
Women's Health - Vaginal Infections Drug Pipeline Report
 February 2008 £650
Metabolic Endocrinology - Diabetic Neuropathy Drug Pipeline Report
 February 2008 £650
Women's Health - Infertility Drug Pipeline Report
 February 2008 £650
Women's Health - Female Sexual Dysfunction Drug Pipeline Report
 February 2008 £650
Substance Abuse - Poisoning Drug Pipeline Report
 February 2008 £650
Substance Abuse - Smoking Cessation Drug Pipeline Report
 February 2008 £650
Women's Health - Contraception Drug Pipeline Report
 February 2008 £650
Ovarian Cancer Drug Pipeline Report
 February 2008 £975
Women's Health - Endometriosis Drug Pipeline Report
 February 2008 £650
Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report
 February 2008 £975
Metabolic Endocrinology - Vitamin Deficiency Drug Pipeline Report
 February 2008 £650
Multiple Myeloma Drug Pipeline Report
 February 2008 £975
Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report
 February 2008 £650
Metabolic Endocrinology - Hypogonadism Drug Pipeline Report
 February 2008 £650
Metabolic Endocrinology - Hypercalcemia Drug Pipeline Report
 February 2008 £650
Ophthalmology and Optometry - Ocular Inflammation Drug Pipeline Report
 February 2008 £650
Metabolic Endocrinology - Hypocalcemia Drug Pipeline Report
 February 2008 £650
Musculo-Skeletal-Disorders - Gout Drug Pipeline Report
 February 2008 £650
Metabolic Endocrinology - Obesity Drug Pipeline Report
 February 2008 £975
Ophthalmology and Optometry - Eye Infections Drug Pipeline Report
 February 2008 £650
Musculo-Skeletal-Disorders - Muscle Pain Drug Pipeline Report
 February 2008 £650
Ophthalmology and Optometry - Macular Degeneration Drug Pipeline Report
 February 2008 £975
Ophthalmology and Optometry - Glaucoma Drug Pipeline Report
 February 2008 £975
Ophthalmology and Optometry - Conjunctivitis Drug Pipeline Report
 February 2008 £650
Ophthalmology and Optometry - Dry Eyes Drug Pipeline Report
 February 2008 £650
Non-Hodgkin Lymphoma Drug Pipeline Report
 February 2008 £975
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Drug Pipeline Report
 February 2008 £975
Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report
 February 2008 £975
Shire plc -Detailed Product Pipeline
 February 2008 £245
Simcere Pharmaceutical Group. -Detailed Product Pipeline
 February 2008 £245
Sinobiomed Inc. -Detailed Product Pipeline
 February 2008 £245
Sepracor Inc -Detailed Product Pipeline
 February 2008 £245
Sirtris Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Sinofresh Healthcare Inc -Detailed Product Pipeline
 February 2008 £245
Sinovac Biotech Ltd -Detailed Product Pipeline
 February 2008 £245
SciClone Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
SkyePharma Plc -Detailed Product Pipeline
 February 2008 £245
Savient Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Schering -Plough Corp -Detailed Product Pipeline
 February 2008 £245
Schwarz Pharma Ag -Detailed Product Pipeline
 February 2008 £245
Seattle Genetics Inc -Detailed Product Pipeline
 February 2008 £245
Sciele Pharma, Inc. -Detailed Product Pipeline
 February 2008 £245
Senetek Plc -Detailed Product Pipeline
 February 2008 £245
StemCells Inc -Detailed Product Pipeline
 February 2008 £245
Sucampo Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Stryker Corp -Detailed Product Pipeline
 February 2008 £245
Sunesis Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
SuperGen Inc -Detailed Product Pipeline
 February 2008 £245
Santarus Inc -Detailed Product Pipeline
 February 2008 £245
Swiss Medica Inc -Detailed Product Pipeline
 February 2008 £245
Stem Cell Innovations Inc -Detailed Product Pipeline
 February 2008 £245
Stellar Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Somaxon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Solbec Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £245
Sonus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Spectrum Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Starpharma Holdings Ltd -Detailed Product Pipeline
 February 2008 £245
Spherix Incorporated -Detailed Product Pipeline
 February 2008 £245
Smith & Nephew Plc -Detailed Product Pipeline
 February 2008 £245
Questcor Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Psivida Ltd -Detailed Product Pipeline
 February 2008 £245
Provectus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
QLT Inc -Detailed Product Pipeline
 February 2008 £245
Sygnis Pharma AG -Detailed Product Pipeline
 February 2008 £245
Regen Therapeutics plc -Detailed Product Pipeline
 February 2008 £245
Raptor Pharmaceuticals Corp. -Detailed Product Pipeline
 February 2008 £245
Protherics PLC -Detailed Product Pipeline
 February 2008 £245
Proteo Inc -Detailed Product Pipeline
 February 2008 £245
Procyon Corp. -Detailed Product Pipeline
 February 2008 £245
Procter & Gamble Company -Detailed Product Pipeline
 February 2008 £245
Progen Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £245
Progenics Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Protalix BioTherapeutics, Inc. -Detailed Product Pipeline
 February 2008 £245
Protalex Inc -Detailed Product Pipeline
 February 2008 £245
RegeneRx Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Regeneron Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
SIGA Technologies Inc -Detailed Product Pipeline
 February 2008 £245
SGX Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Salix Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £245
Samaritan Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Sanguine Corp -Detailed Product Pipeline
 February 2008 £245
Sangamo BioSciences Inc -Detailed Product Pipeline
 February 2008 £245
SCOLR Pharma Inc -Detailed Product Pipeline
 February 2008 £245
Roche Holdings Ltd -Detailed Product Pipeline
 February 2008 £245
Replidyne Inc -Detailed Product Pipeline
 February 2008 £245
Renovis Inc -Detailed Product Pipeline
 February 2008 £245
Repligen Corporation -Detailed Product Pipeline
 February 2008 £245
Repros Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Rigel Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Rexahn Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Sanofi -Aventis -Detailed Product Pipeline
 February 2008 £245
Titan Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Viragen Inc -Detailed Product Pipeline
 February 2008 £245
Vion Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Viral Genetics Inc -Detailed Product Pipeline
 February 2008 £245
Viropharma Inc -Detailed Product Pipeline
 February 2008 £245
Vyrex Corp -Detailed Product Pipeline
 February 2008 £245
Vital Living Inc -Detailed Product Pipeline
 February 2008 £245
VioQuest Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Vical Inc -Detailed Product Pipeline
 February 2008 £245
Vaso Active Pharmaceuticals -Detailed Product Pipeline
 February 2008 £245
Vanda Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Vasogen Inc -Detailed Product Pipeline
 February 2008 £245
Vernalis Plc ADR -Detailed Product Pipeline
 February 2008 £245
ViRexx Medical Corp -Detailed Product Pipeline
 February 2008 £245
Vertex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Vyteris Holdings (Nevada) Inc -Detailed Product Pipeline
 February 2008 £245
Warner Chilcott Limited -Detailed Product Pipeline
 February 2008 £245
ZIOPHARM Oncology Inc -Detailed Product Pipeline
 February 2008 £245
YM BioSciences Inc -Detailed Product Pipeline
 February 2008 £245
Zila Inc -Detailed Product Pipeline
 February 2008 £245
ZymoGenetics Inc -Detailed Product Pipeline
 February 2008 £245
Pro -Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
deCODE genetics Inc -Detailed Product Pipeline
 February 2008 £245
Xenoport Inc -Detailed Product Pipeline
 February 2008 £245
Xechem International Inc. -Detailed Product Pipeline
 February 2008 £245
Women First Healthcare Inc. -Detailed Product Pipeline
 February 2008 £245
Watson Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Wyeth -Detailed Product Pipeline
 February 2008 £245
XELR8, Inc. -Detailed Product Pipeline
 February 2008 £245
XTL Biopharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £245
XOMA Ltd -Detailed Product Pipeline
 February 2008 £245
Valeant Pharmaceuticals International -Detailed Product Pipeline
 February 2008 £245
VIVUS Inc -Detailed Product Pipeline
 February 2008 £245
Targeted Genetics Corp -Detailed Product Pipeline
 February 2008 £245
Targanta Therapeutics Corp. -Detailed Product Pipeline
 February 2008 £245
Taro Pharmaceutical Industries Ltd -Detailed Product Pipeline
 February 2008 £245
Telik Inc -Detailed Product Pipeline
 February 2008 £245
Tetragenex Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Tercica Inc -Detailed Product Pipeline
 February 2008 £245
Targacept Inc -Detailed Product Pipeline
 February 2008 £245
Tapestry Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Synta Pharmaceuticals Corp. -Detailed Product Pipeline
 February 2008 £245
Synovics Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
SyntheMed Inc -Detailed Product Pipeline
 February 2008 £245
Synthetic Blood International Inc -Detailed Product Pipeline
 February 2008 £245
TapImmune, Inc. -Detailed Product Pipeline
 February 2008 £245
Synvista Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £245
Teva Pharmaceutical Industries Ltd -Detailed Product Pipeline
 February 2008 £245
The Medicines Company -Detailed Product Pipeline
 February 2008 £245
USANA Health Sciences Inc -Detailed Product Pipeline
 February 2008 £245
ULURU Inc -Detailed Product Pipeline
 February 2008 £245
Unigene Laboratories Inc -Detailed Product Pipeline
 February 2008 £245
United Therapeutics Corporation -Detailed Product Pipeline
 February 2008 £245
VIA Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Urigen Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Trubion Pharmaceuticals Inc. -Detailed Product Pipeline
 February 2008 £245
Trimeris Inc -Detailed Product Pipeline
 February 2008 £245
Theravance Inc -Detailed Product Pipeline
 February 2008 £245
The Quigley Corporation -Detailed Product Pipeline
 February 2008 £245
Threshold Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
TorreyPines Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £245
Transition Therapeutics Inc. -Detailed Product Pipeline
 February 2008 £245
Symbollon Pharmaceuticals Inc CL A -Detailed Product Pipeline
 February 2008 £245
Orexigen Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £245
Dragon Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £245
Duska Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Dyax Corp -Detailed Product Pipeline
 February 2008 £245
Dynavax Technologies Corp -Detailed Product Pipeline
 February 2008 £245
Dr Reddys Laboratories Ltd -Detailed Product Pipeline
 February 2008 £245
Dov Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £245
Derma Sciences Inc -Detailed Product Pipeline
 February 2008 £245
Diamyd Medical AB -Detailed Product Pipeline
 February 2008 £245
Discovery Laboratories Inc -Detailed Product Pipeline
 February 2008 £245
Dnaprint Genomics Inc -Detailed Product Pipeline
 February 2008 £245
EPIX Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Echo Therapeutics, Inc -Detailed Product Pipeline
 February 2008 £245
Emisphere Technologies Inc -Detailed Product Pipeline
 February 2008 £245
Encysive Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Endo Pharmaceuticals Holdings Inc -Detailed Product Pipeline
 February 2008 £245
Endovasc Inc (NV) -Detailed Product Pipeline
 February 2008 £245
Emergent BioSolutions Inc -Detailed Product Pipeline
 February 2008 £245
Elite Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Eisai Co Ltd -Detailed Product Pipeline
 February 2008 £245
Elan Corp Plc -Detailed Product Pipeline
 February 2008 £245
Eli Lilly & Co -Detailed Product Pipeline
 February 2008 £245
Depomed Inc -Detailed Product Pipeline
 February 2008 £245
Dendreon Corp -Detailed Product Pipeline
 February 2008 £245
Curis Inc -Detailed Product Pipeline
 February 2008 £245
Cyanotech Corporation -Detailed Product Pipeline
 February 2008 £245
Cyclacel Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Cyplasin Biomedical Ltd. -Detailed Product Pipeline
 February 2008 £245
CuraGen Corp -Detailed Product Pipeline
 February 2008 £245
Cubist Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Cougar Biotechnology, Inc. -Detailed Product Pipeline
 February 2008 £245
Critical Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Crucell N V -Detailed Product Pipeline
 February 2008 £245
Cypress Bioscience Incorporated -Detailed Product Pipeline
 February 2008 £245
CytRx Corporation -Detailed Product Pipeline
 February 2008 £245
DOR BioPharma Inc -Detailed Product Pipeline
 February 2008 £245
DRAXIS Health Inc -Detailed Product Pipeline
 February 2008 £245
DURECT Corporation -Detailed Product Pipeline
 February 2008 £245
DUSA Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
DENTSPLY International Inc -Detailed Product Pipeline
 February 2008 £245
Cytos Biotechnology AG -Detailed Product Pipeline
 February 2008 £245
CytoDyn Inc -Detailed Product Pipeline
 February 2008 £245
Cytogenix Inc -Detailed Product Pipeline
 February 2008 £245
Cytokinetics Inc -Detailed Product Pipeline
 February 2008 £245
Enhance Biotech Inc -Detailed Product Pipeline
 February 2008 £245
EntreMed Inc -Detailed Product Pipeline
 February 2008 £245
Gentium S.p.A -Detailed Product Pipeline
 February 2008 £245
Genzyme Corporation -Detailed Product Pipeline
 February 2008 £245
GeoPharma Inc -Detailed Product Pipeline
 February 2008 £245
GeoVax Labs Inc -Detailed Product Pipeline
 February 2008 £245
Genta Incorporated -Detailed Product Pipeline
 February 2008 £245
Genitope Corp -Detailed Product Pipeline
 February 2008 £245
Genelabs Technologies Inc -Detailed Product Pipeline
 February 2008 £245
Genentech Inc -Detailed Product Pipeline
 February 2008 £245
Generex Biotechnology Corporation -Detailed Product Pipeline
 February 2008 £245
Geron Corporation -Detailed Product Pipeline
 February 2008 £245
Gilead Sciences Inc -Detailed Product Pipeline
 February 2008 £245
Hemispherx Biopharma Inc -Detailed Product Pipeline
 February 2008 £245
Hemobiotech Inc -Detailed Product Pipeline
 February 2008 £245
Hi -Tech Pharmacal Co Inc -Detailed Product Pipeline
 February 2008 £245
Hollis -Eden Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Helix BioMedix Inc -Detailed Product Pipeline
 February 2008 £245
Hana Biosciences Inc -Detailed Product Pipeline
 February 2008 £245
GlaxoSmithKline plc -Detailed Product Pipeline
 February 2008 £245
H.Lundbeck AS -Detailed Product Pipeline
 February 2008 £245
Prescient NeuroPharma Inc -Detailed Product Pipeline
 February 2008 £245
Genaera Corporation -Detailed Product Pipeline
 February 2008 £245
GenVec Inc -Detailed Product Pipeline
 February 2008 £245
Eugene Science Inc -Detailed Product Pipeline
 February 2008 £245
Eurand N.V. -Detailed Product Pipeline
 February 2008 £245
Exelixis Inc -Detailed Product Pipeline
 February 2008 £245
Favrille Inc -Detailed Product Pipeline
 February 2008 £245
Eqitx Ltd -Detailed Product Pipeline
 February 2008 £245
Epigenomics AG -Detailed Product Pipeline
 February 2008 £245
Enzo Biochem Inc -Detailed Product Pipeline
 February 2008 £245
Enzon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
EpiCept Corp -Detailed Product Pipeline
 February 2008 £245
Flamel Technologies SA ADS -Detailed Product Pipeline
 February 2008 £245
Forbes Medi -Tech Inc -Detailed Product Pipeline
 February 2008 £245
GW Pharmaceuticals PLC -Detailed Product Pipeline
 February 2008 £245
GammaCan International Inc -Detailed Product Pipeline
 February 2008 £245
Gedeon Richter Ltd -Detailed Product Pipeline
 February 2008 £245
GelStat Corp -Detailed Product Pipeline
 February 2008 £245
GTX INC -Detailed Product Pipeline
 February 2008 £245
GTC Biotherapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Forest Laboratories Inc -Detailed Product Pipeline
 February 2008 £245
Forticell Bioscience, Inc. -Detailed Product Pipeline
 February 2008 £245
GPC Biotech AG -Detailed Product Pipeline
 February 2008 £245
Cortex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Corcept Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Bentley Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Bio -Bridge Science Inc -Detailed Product Pipeline
 February 2008 £245
BioCryst Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
BioDelivery Sciences International Inc -Detailed Product Pipeline
 February 2008 £245
Benitec Ltd -Detailed Product Pipeline
 February 2008 £245
Benda Pharmaceutical, Inc -Detailed Product Pipeline
 February 2008 £245
Baxter International Inc -Detailed Product Pipeline
 February 2008 £245
Bayer Ag -Detailed Product Pipeline
 February 2008 £245
Bayer Schering Pharma AG -Detailed Product Pipeline
 February 2008 £245
Beijing Med -Pharm Corp. -Detailed Product Pipeline
 February 2008 £245
BioForm Medical, Inc. -Detailed Product Pipeline
 February 2008 £245
BioMarin Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £245
Biocon Ltd -Detailed Product Pipeline
 February 2008 £245
Biodel Inc. -Detailed Product Pipeline
 February 2008 £245
Biogen Idec Inc -Detailed Product Pipeline
 February 2008 £245
Bioniche Life Sciences Inc -Detailed Product Pipeline
 February 2008 £245
BioTime Inc -Detailed Product Pipeline
 February 2008 £245
BioSphere Medical Inc -Detailed Product Pipeline
 February 2008 £245
BioMimetic Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
BioSante Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
BioSpecifics Technologies Corp -Detailed Product Pipeline
 February 2008 £245
Bavarian Nordic AS -Detailed Product Pipeline
 February 2008 £245
Basilea Pharmaceutica AG -Detailed Product Pipeline
 February 2008 £245
AVI BioPharma Inc -Detailed Product Pipeline
 February 2008 £245
AXM Pharma Inc -Detailed Product Pipeline
 February 2008 £245
Amicus Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £245
Anavex Life Sciences Corp. -Detailed Product Pipeline
 February 2008 £245
AVAX TECHNOLOGIES INCORPORATED -Detailed Product Pipeline
 February 2008 £245
AVANT Immunotherapeutics Inc -Detailed Product Pipeline
 February 2008 £245
World Health Energy, Inc. -Detailed Product Pipeline
 February 2008 £245
3SBio Inc. -Detailed Product Pipeline
 February 2008 £245
AVANIR Pharmaceuticals -Detailed Product Pipeline
 February 2008 £245
Arana Therapeutics Limited -Detailed Product Pipeline
 February 2008 £245
Ardea Biosciences, Inc. -Detailed Product Pipeline
 February 2008 £245
Avigen Inc -Detailed Product Pipeline
 February 2008 £245
Axcan Pharma Inc -Detailed Product Pipeline
 February 2008 £245
Barr Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Barrier Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Avicena Group Inc -Detailed Product Pipeline
 February 2008 £245
Avantogen Oncology, Inc. -Detailed Product Pipeline
 February 2008 £245
AstraZeneca Plc -Detailed Product Pipeline
 February 2008 £245
Auxilium Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Avalon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Bionovo Inc -Detailed Product Pipeline
 February 2008 £245
Biophage Pharma Inc -Detailed Product Pipeline
 February 2008 £245
Ceragenix Phamaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Cerus Corporation -Detailed Product Pipeline
 February 2008 £245
Chattem Inc -Detailed Product Pipeline
 February 2008 £245
Chelsea Therapeutics International Ltd -Detailed Product Pipeline
 February 2008 £245
Cephalon Inc -Detailed Product Pipeline
 February 2008 £245
Celsion Corp -Detailed Product Pipeline
 February 2008 £245
Cell Genesys Inc -Detailed Product Pipeline
 February 2008 £245
Cell Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Cellegy Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Chemgenex Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £245
Chemokine Therapeutics Corp -Detailed Product Pipeline
 February 2008 £245
CollaGenex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Columbia Laboratories Inc -Detailed Product Pipeline
 February 2008 £245
CombinatoRx Inc -Detailed Product Pipeline
 February 2008 £245
Compugen Ltd -Detailed Product Pipeline
 February 2008 £245
Cobalis Corp -Detailed Product Pipeline
 February 2008 £245
Clinuvel Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £245
Chugai Pharmaceutical Co Ltd -Detailed Product Pipeline
 February 2008 £245
Cleveland Biolabs Inc -Detailed Product Pipeline
 February 2008 £245
Clinical Data Inc -Detailed Product Pipeline
 February 2008 £245
Celgene Corporation -Detailed Product Pipeline
 February 2008 £245
CeNeS Pharmaceuticals Plc -Detailed Product Pipeline
 February 2008 £245
Bradley Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Brainstorm Cell Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Bristol -Myers Squibb Company -Detailed Product Pipeline
 February 2008 £245
CEL -SCI Corporation -Detailed Product Pipeline
 February 2008 £245
Biovest International Inc. -Detailed Product Pipeline
 February 2008 £245
Biovail Corporation -Detailed Product Pipeline
 February 2008 £245
Biopure Corporation -Detailed Product Pipeline
 February 2008 £245
Biosyntech Inc -Detailed Product Pipeline
 February 2008 £245
Biotech Holdings Ltd -Detailed Product Pipeline
 February 2008 £245
CV Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
CYTOGEN Corporation -Detailed Product Pipeline
 February 2008 £245
Cardium Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Carribbean American Health Resorts Inc -Detailed Product Pipeline
 February 2008 £245
Carrington Laboratories Inc -Detailed Product Pipeline
 February 2008 £245
Catalyst Pharmaceutical Partners Inc. -Detailed Product Pipeline
 February 2008 £245
Cardiome Pharma Corp -Detailed Product Pipeline
 February 2008 £245
CardioVascular BioTherapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Cadence Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Callisto Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Caraco Pharmaceutical Laboratories Ltd -Detailed Product Pipeline
 February 2008 £245
Hologic Inc -Detailed Product Pipeline
 February 2008 £245
Halozyme Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Novelos Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Noven Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Novo -Nordisk A -Detailed Product Pipeline
 February 2008 £245
Novogen Ltd -Detailed Product Pipeline
 February 2008 £245
Novavax Inc -Detailed Product Pipeline
 February 2008 £245
Novartis AG -Detailed Product Pipeline
 February 2008 £245
Northwest Biotherapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Novacea Inc -Detailed Product Pipeline
 February 2008 £245
Novadel Pharma Inc -Detailed Product Pipeline
 February 2008 £245
Novozymes A -Detailed Product Pipeline
 February 2008 £245
Nucryst Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £245
OSI Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
OXIS International Inc -Detailed Product Pipeline
 February 2008 £245
OXiGENE INC -Detailed Product Pipeline
 February 2008 £245
Oculus Innovative Sciences Inc -Detailed Product Pipeline
 February 2008 £245
Nymox Pharmaceutical Corporation -Detailed Product Pipeline
 February 2008 £245
Nventa Biopharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £245
Nutra Pharma Corp -Detailed Product Pipeline
 February 2008 £245
Nutrition 21 Inc -Detailed Product Pipeline
 February 2008 £245
Nuvelo Inc. -Detailed Product Pipeline
 February 2008 £245
Northfield Laboratories Inc -Detailed Product Pipeline
 February 2008 £245
North American Scientific Inc -Detailed Product Pipeline
 February 2008 £245
NatureWell Inc -Detailed Product Pipeline
 February 2008 £245
Hospira Inc -Detailed Product Pipeline
 February 2008 £245
NeoPharm Inc -Detailed Product Pipeline
 February 2008 £245
Neose Technologies Inc -Detailed Product Pipeline
 February 2008 £245
Nastech Pharmaceutical Co Inc -Detailed Product Pipeline
 February 2008 £245
NanoViricides, Inc. -Detailed Product Pipeline
 February 2008 £245
Myriad Genetics Inc -Detailed Product Pipeline
 February 2008 £245
NPS Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Nabi Biopharmaceuticals -Detailed Product Pipeline
 February 2008 £245
Neuro -Hitech Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Neurobiological Technologies Inc -Detailed Product Pipeline
 February 2008 £245
Neurologix Inc -Detailed Product Pipeline
 February 2008 £245
NexMed Inc -Detailed Product Pipeline
 February 2008 £245
Nile Therapeutics, Inc -Detailed Product Pipeline
 February 2008 £245
Nitromed Inc -Detailed Product Pipeline
 February 2008 £245
NeurogesX, Inc. -Detailed Product Pipeline
 February 2008 £245
Neurogenesis Inc -Detailed Product Pipeline
 February 2008 £245
Neurochem Inc -Detailed Product Pipeline
 February 2008 £245
Neurocrine Biosciences Inc -Detailed Product Pipeline
 February 2008 £245
Neurogen Corporation -Detailed Product Pipeline
 February 2008 £245
Omrix Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
OncoVista, Inc. -Detailed Product Pipeline
 February 2008 £245
Pharmacyclics Inc -Detailed Product Pipeline
 February 2008 £245
Pharmasset, Inc. -Detailed Product Pipeline
 February 2008 £245
Pharmaxis Ltd. -Detailed Product Pipeline
 February 2008 £245
Pharming Group N.V. -Detailed Product Pipeline
 February 2008 £245
Pharmacopeia, Inc. -Detailed Product Pipeline
 February 2008 £245
Pfizer Inc -Detailed Product Pipeline
 February 2008 £245
Peplin Ltd -Detailed Product Pipeline
 February 2008 £245
Peregrine Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Perrigo Company -Detailed Product Pipeline
 February 2008 £245
Pharmion Corp -Detailed Product Pipeline
 February 2008 £245
Pharmos Corporation -Detailed Product Pipeline
 February 2008 £245
Point Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Polydex Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £245
Poniard Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Prana Biotechnology Ltd -Detailed Product Pipeline
 February 2008 £245
Pluristem Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £245
Pipex Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Phosphagenics Ltd. -Detailed Product Pipeline
 February 2008 £245
Phytopharm PLC -Detailed Product Pipeline
 February 2008 £245
Pilot Therapeutics Holdings Inc -Detailed Product Pipeline
 February 2008 £245
Penwest Pharmaceuticals Co -Detailed Product Pipeline
 February 2008 £245
Par Pharmaceutical Companies Inc -Detailed Product Pipeline
 February 2008 £245
Optimer Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Oragenics Inc -Detailed Product Pipeline
 February 2008 £245
Oramed Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Orchid Chemicals & Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £245
Opko Health, Inc. -Detailed Product Pipeline
 February 2008 £245
Opexa Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Oncolytics Biotech Inc -Detailed Product Pipeline
 February 2008 £245
Oncothyreon, Inc. -Detailed Product Pipeline
 February 2008 £245
Onyx Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
OrthoLogic Corporation -Detailed Product Pipeline
 February 2008 £245
Orthovita Inc -Detailed Product Pipeline
 February 2008 £245
PacificHealth Laboratories Inc -Detailed Product Pipeline
 February 2008 £245
Pain Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Palatin Technologies Inc -Detailed Product Pipeline
 February 2008 £245
Panacos Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
POZEN Inc -Detailed Product Pipeline
 February 2008 £245
PDL BioPharma Inc -Detailed Product Pipeline
 February 2008 £245
Oscient Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £245
Osiris Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Osteologix, Inc. -Detailed Product Pipeline
 February 2008 £245
Mymetics Corporation -Detailed Product Pipeline
 February 2008 £245
Nektar Therapeutics -Detailed Product Pipeline
 February 2008 £245
InterMune Inc -Detailed Product Pipeline
 February 2008 £245
Interpharm Holdings Inc -Detailed Product Pipeline
 February 2008 £245
Introgen Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Inyx Inc -Detailed Product Pipeline
 February 2008 £245
Intellect Neurosciences, Inc. -Detailed Product Pipeline
 February 2008 £245
IntelGenx Technologies Corp. -Detailed Product Pipeline
 February 2008 £245
Inovio Biomedical Corp -Detailed Product Pipeline
 February 2008 £245
Insmed Incorporated -Detailed Product Pipeline
 February 2008 £245
Inspire Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Iomai Corp -Detailed Product Pipeline
 February 2008 £245
Isis Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Keryx Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
King Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Kosan Biosciences Incorporated -Detailed Product Pipeline
 February 2008 £245
Kyto BioPharma Inc -Detailed Product Pipeline
 February 2008 £245
KV Pharmaceutical Co. -Detailed Product Pipeline
 February 2008 £245
Johnson & Johnson -Detailed Product Pipeline
 February 2008 £245
IsoRay Inc -Detailed Product Pipeline
 February 2008 £245
Javelin Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Mylan, Inc. -Detailed Product Pipeline
 February 2008 £245
Innovive Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Inhibitex Inc -Detailed Product Pipeline
 February 2008 £245
Idenix Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Idera Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Imagenetix Inc -Detailed Product Pipeline
 February 2008 £245
Imarx Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £245
ISTA Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
IMCOR Pharmaceutical Co. -Detailed Product Pipeline
 February 2008 £245
Human Genome Sciences Inc -Detailed Product Pipeline
 February 2008 £245
ICAgen Inc -Detailed Product Pipeline
 February 2008 £245
IDM Pharma Inc -Detailed Product Pipeline
 February 2008 £245
Imclone Systems Inc -Detailed Product Pipeline
 February 2008 £245
Immtech Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Incyte Corporation -Detailed Product Pipeline
 February 2008 £245
Indevus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Infinity Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Inflazyme Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £245
InSite Vision Incorporated -Detailed Product Pipeline
 February 2008 £245
InNexus Biotechnology Inc -Detailed Product Pipeline
 February 2008 £245
ImmunoGen Inc -Detailed Product Pipeline
 February 2008 £245
Immunomedics Inc -Detailed Product Pipeline
 February 2008 £245
Impax Laboratories Inc -Detailed Product Pipeline
 February 2008 £245
LAM Pharmaceutical Corp -Detailed Product Pipeline
 February 2008 £245
Jazz Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
La Jolla Pharmaceutical Co -Detailed Product Pipeline
 February 2008 £245
Metabasis Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Metabolic Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £245
MethylGene Inc -Detailed Product Pipeline
 February 2008 £245
Mentor Corporation -Detailed Product Pipeline
 February 2008 £245
Memory Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £245
Medicis Pharmaceutical Corp -Detailed Product Pipeline
 February 2008 £245
Medicure Inc -Detailed Product Pipeline
 February 2008 £245
Medivation Inc -Detailed Product Pipeline
 February 2008 £245
Meldex International Plc -Detailed Product Pipeline
 February 2008 £245
MicroIslet, Inc. -Detailed Product Pipeline
 February 2008 £245
Micromet Inc -Detailed Product Pipeline
 February 2008 £245
Modigene, Inc. -Detailed Product Pipeline
 February 2008 £245
Molecular Insight Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Momenta Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
MultiCell Technologies Inc -Detailed Product Pipeline
 February 2008 £245
Miravant Medical Technologies -Detailed Product Pipeline
 February 2008 £245
Minrad International Inc -Detailed Product Pipeline
 February 2008 £245
MiddleBrook Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Migenix Inc -Detailed Product Pipeline
 February 2008 £245
Millennium Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
MediciNova Inc -Detailed Product Pipeline
 February 2008 £245
Merck & Co Inc -Detailed Product Pipeline
 February 2008 £245
Lexicon Pharmaceuticals, Inc -Detailed Product Pipeline
 February 2008 £245
Ligand Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Lorus Therapeutics Inc -Detailed Product Pipeline
 February 2008 £245
Lotus Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £245
Lev Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £245
Lescarden Inc -Detailed Product Pipeline
 February 2008 £245
Labopharm Inc -Detailed Product Pipeline
 February 2008 £245
Lannett Co Inc -Detailed Product Pipeline
 February 2008 £245
Medarex Inc -Detailed Product Pipeline
 February 2008 £245
Lpath Inc -Detailed Product Pipeline
 February 2008 £245
Lee Pharmaceuticals -Detailed Product Pipeline
 February 2008 £245
Matrixx Initiatives Inc -Detailed Product Pipeline
 February 2008 £245
Maxygen Inc -Detailed Product Pipeline
 February 2008 £245
Med Gen Inc -Detailed Product Pipeline
 February 2008 £245
Mannatech Inc -Detailed Product Pipeline
 February 2008 £245
Marshall Edwards Inc -Detailed Product Pipeline
 February 2008 £245
MGI Pharma Inc -Detailed Product Pipeline
 February 2008 £245
MannKind Corp -Detailed Product Pipeline
 February 2008 £245
MacroChem Corporation -Detailed Product Pipeline
 February 2008 £245
Manhattan Pharmaceuticals Inc. -Detailed Product Pipeline
 February 2008 £245
Commercial and Pipeline Insight: Hepatitis B
 October 2007 £4960
Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA
 August 2007 £5230
Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products
 August 2007 £5230
Pipeline Insight: Heart failure Week pipeline dominated by new indications and add-on diuretics
 August 2007 £3915
Pipeline And Commercial Insight
Pediatric And Adolescent Vaccines
 July 2007 £5225
Indication Expansion
Opportunities for successful lifecycle management
 March 2007 £1495
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
 February 2007 £1495
New Drug Futures: Cancer Chapter
 May 2006 £695
New Drug Futures: Anti-Infective Chapter
 May 2006 £695
New Drug Futures
 May 2006 £2995
New Drug Futures: Cardiovascular Chapter
 May 2006 £695
New Drug Futures: Alimentary/Metabolic Chapter
 May 2006 £695
New Drug Futures: Musculoskeletal Chapter
 May 2006 £695
New Drug Futures: Respiratory Chapter
 May 2006 £695
New Drug Futures: Central Nervous System Chapter
 May 2006 £695
New Drug Futures: Vaccines Chapter
 May 2006 £695
The Impact of the Phase III Pipeline
Future Projections and Market Disruptions
 March 2006 £2285